“Wallonia was our obvious choice,” explains Cécile Jacoby, General Manager of Q1 Scientific Belgium. The Liège region is located at the heart of a pharmaceutical and biotechnology hub, close to major cities such as Brussels and Leuven, and major transport links (Liege Airport). All this is backed by Wallonia’s solid infrastructure, skilled workforce and efficient support from local authorities and development agencies such as AWEX. “Villers-le-Bouillet offers the ideal combination of a strategic location, a talent pool, and facilities, all of which will enable us to provide the most effective service to pharmaceutical companies in Belgium and continental Europe.”

These are all key factors for the Belgian subsidiary’s activities. Q1 Scientific Belgium supports stability testing for manufacturers of medicines, vaccines and other healthcare products by ensuring optimal storage thanks to controlled temperature and humidity conditions, in order to guarantee their safety and efficacy. “At Villers-le-Bouillet, we also offer Good Distribution Practice-certified storage for finished products that are ready for delivery to hospitals, pharmacies, and patients.”

“Since opening in May 2023, we have signed many commercial partnerships with pharmaceutical and biotech companies, including QUALIblood, a contract research organisation based in Belgium that works with pharmaceutical companies, in vitro diagnostics companies, hospitals, and universities, by providing analysis services for blood tests and hemocompatibility testing.”

The growth of Q1 Scientific Belgium is part of the company’s international expansion, which has also seen it open a subsidiary in the United States.

WAB Magazine